Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company has market cap of $496.87 million. The firm operates through three divisions: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. It has a 277.96 P/E ratio. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch local nurses and allied staffing; and short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments.
Douglas Howell, the well informed man, currently the VP & Chief Financial Officer of Gallagher Arthur J & Co made a sale of approximately 5,200 shares of the company valued by the market at roughly $354,484 US Dollars based on an average price of 68.2 US Dollars a share. Currently, Douglas Howell owns 37,800 shares which make up exactly 0.02% of the Company’s total market capitalization. The document was revealed in a filing dated February 16, 2018 with the SEC.
The stock increased 3.89% or $0.51 during the last trading session, reaching $13.62. About 160,625 shares traded. Cross Country Healthcare, Inc. (CCRN) has declined 8.78% since February 17, 2017 and is downtrending. It has underperformed by 25.48% the S&P500.
Since January 1, 0001, it had 0 insider purchases, and 1 insider sale for $596,989 activity.
Ratings analysis reveals 50% of Cross Country’s analysts are positive. Out of 2 Wall Street analysts rating Cross Country, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. CCRN was included in 2 notes of analysts from January 20, 2017. Avondale downgraded the shares of CCRN in report on Tuesday, January 24 to “Mkt Perform” rating. Benchmark initiated it with “Buy” rating and $19.0 target in Friday, January 20 report.
Hawk Ridge Capital Management Lp holds 2.32% of its portfolio in Cross Country Healthcare, Inc. for 434,082 shares. Alphaone Investment Services Llc owns 454,788 shares or 1.72% of their US portfolio. Moreover, Skyline Asset Management Lp has 1.49% invested in the company for 1.32 million shares. The California-based Engaged Capital Llc has invested 0.99% in the stock. Eagle Boston Investment Management Inc, a Massachusetts-based fund reported 660,195 shares.
Analysts await Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report earnings on March, 7. They expect $0.19 earnings per share, down 5.00% or $0.01 from last year’s $0.2 per share. CCRN’s profit will be $6.93M for 17.92 P/E if the $0.19 EPS becomes a reality. After $0.23 actual earnings per share reported by Cross Country Healthcare, Inc. for the previous quarter, Wall Street now forecasts -17.39% negative EPS growth.
Arthur J. Gallagher & Co., together with its subsidiaries, provides insurance brokerage and risk management services in the United States and internationally. The company has market cap of $12.51 billion. The Company’s Brokerage segment consists of retail and wholesale insurance brokerage operations. It has a 27.15 P/E ratio. The companyÂ’s retail brokerage activities negotiate and place property/casualty, employer-provided health and welfare insurance, and healthcare exchange and retirement solutions primarily for middle-market commercial, industrial, public entity, religious, and not-for-profit entities.
Investors sentiment decreased to 1.08 in Q3 2017. Its down 0.45, from 1.53 in 2017Q2. It turned negative, as 33 investors sold Arthur J. Gallagher & Co. shares while 153 reduced holdings. 59 funds opened positions while 141 raised stakes. 143.95 million shares or 0.70% more from 142.95 million shares in 2017Q2 were reported. Sumitomo Mitsui Asset, a Japan-based fund reported 14,053 shares. Cibc Asset Mngmt Incorporated holds 0.01% or 20,775 shares in its portfolio. Vaughan Nelson Investment Mngmt L P holds 1.2% in Arthur J. Gallagher & Co. (NYSE:AJG) or 1.64 million shares. Moreover, Deprince Race And Zollo has 0.06% invested in Arthur J. Gallagher & Co. (NYSE:AJG). Chevy Chase Holdg holds 0.04% of its portfolio in Arthur J. Gallagher & Co. (NYSE:AJG) for 157,715 shares. 9.23 million are held by Jpmorgan Chase Communications. Maryland-based Price T Rowe Associate Md has invested 0.01% in Arthur J. Gallagher & Co. (NYSE:AJG). Smithfield Trust holds 0.01% in Arthur J. Gallagher & Co. (NYSE:AJG) or 1,590 shares. Lawson Kroeker Invest Mngmt Ne owns 145,685 shares. Connecticut-based Cubist Systematic Strategies has invested 0.01% in Arthur J. Gallagher & Co. (NYSE:AJG). Champlain Ptnrs Limited Liability Company holds 1.70M shares or 1.23% of its portfolio. 5,000 are held by Washington Capital. Amica Pension Fund Board Of Trustees reported 6,438 shares. Prudential Plc, Illinois-based fund reported 4.71 million shares. The New York-based Renaissance Technology Ltd Limited Liability Company has invested 0.02% in Arthur J. Gallagher & Co. (NYSE:AJG).
Among 14 analysts covering Arthur J. Gallagher (NYSE:AJG), 7 have Buy rating, 1 Sell and 6 Hold. Therefore 50% are positive. Arthur J. Gallagher has $77.0 highest and $44 lowest target. $64.09’s average target is -7.08% below currents $68.97 stock price. Arthur J. Gallagher had 47 analyst reports since August 28, 2015 according to SRatingsIntel. Compass Point maintained the shares of AJG in report on Friday, February 5 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Hold” on Friday, July 28. As per Monday, August 7, the company rating was maintained by Citigroup. The firm has “Market Perform” rating by William Blair given on Monday, March 21. RBC Capital Markets maintained it with “Hold” rating and $64.0 target in Friday, December 8 report. The stock of Arthur J. Gallagher & Co. (NYSE:AJG) earned “Neutral” rating by Citigroup on Friday, February 9. The stock has “Buy” rating by Wells Fargo on Thursday, July 27. The stock has “Buy” rating by SunTrust on Thursday, October 26. The stock of Arthur J. Gallagher & Co. (NYSE:AJG) has “Neutral” rating given on Monday, November 2 by Goldman Sachs. The firm has “Outperform” rating given on Friday, October 27 by Credit Suisse.